SE431092B - Terapeutiskt aktiva, substituerade piperidinkarboxianilider - Google Patents

Terapeutiskt aktiva, substituerade piperidinkarboxianilider

Info

Publication number
SE431092B
SE431092B SE7906000A SE7906000A SE431092B SE 431092 B SE431092 B SE 431092B SE 7906000 A SE7906000 A SE 7906000A SE 7906000 A SE7906000 A SE 7906000A SE 431092 B SE431092 B SE 431092B
Authority
SE
Sweden
Prior art keywords
methyl
quaternary
hydroxyethyl
hydroxypropyl
ethyl
Prior art date
Application number
SE7906000A
Other languages
English (en)
Swedish (sv)
Other versions
SE7906000L (sv
Inventor
Bo Af Ekenstam
Gunnar Aberg
Original Assignee
Thuresson Af Ekenstam Bo
Gunnar Aberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thuresson Af Ekenstam Bo, Gunnar Aberg filed Critical Thuresson Af Ekenstam Bo
Priority to SE7906000A priority Critical patent/SE431092B/sv
Priority to US06/097,148 priority patent/US4302465A/en
Priority to IL60390A priority patent/IL60390A/xx
Priority to ZA00803827A priority patent/ZA803827B/xx
Priority to DE8080850106T priority patent/DE3066827D1/de
Priority to EP80850106A priority patent/EP0024382B1/en
Priority to AT80850106T priority patent/ATE6507T1/de
Priority to AU60032/80A priority patent/AU538494B2/en
Priority to CA000355487A priority patent/CA1162924A/en
Priority to DK290180A priority patent/DK290180A/da
Priority to FI802173A priority patent/FI802173A/fi
Priority to JP9232480A priority patent/JPS5681561A/ja
Priority to PL1980225542A priority patent/PL125596B1/pl
Priority to NZ194284A priority patent/NZ194284A/xx
Priority to ES493230A priority patent/ES8107185A1/es
Priority to CS804889A priority patent/CS227011B2/cs
Priority to HU80801712A priority patent/HU180156B/hu
Priority to NO802062A priority patent/NO802062L/no
Priority to GR62416A priority patent/GR69077B/el
Publication of SE7906000L publication Critical patent/SE7906000L/xx
Publication of SE431092B publication Critical patent/SE431092B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7906000A 1979-07-10 1979-07-10 Terapeutiskt aktiva, substituerade piperidinkarboxianilider SE431092B (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE7906000A SE431092B (sv) 1979-07-10 1979-07-10 Terapeutiskt aktiva, substituerade piperidinkarboxianilider
US06/097,148 US4302465A (en) 1979-07-10 1979-11-26 Therapeutically active, substituted piperidines and pyrrolidines therapeutic compositions thereof and methods of use thereof
IL60390A IL60390A (en) 1979-07-10 1980-06-25 Piperidine derivatives,their preparation and pharmaceutical compositions comprising them
ZA00803827A ZA803827B (en) 1979-07-10 1980-06-26 Therapeutically active, substituted piperidines and pyrrolidines
DE8080850106T DE3066827D1 (en) 1979-07-10 1980-06-27 Piperidine derivatives, their preparation and pharmaceutical compositions containing them
EP80850106A EP0024382B1 (en) 1979-07-10 1980-06-27 Piperidine derivatives, their preparation and pharmaceutical compositions containing them
AT80850106T ATE6507T1 (de) 1979-07-10 1980-06-27 Piperidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU60032/80A AU538494B2 (en) 1979-07-10 1980-07-02 Substituted piperidines and pyrrolidines
CA000355487A CA1162924A (en) 1979-07-10 1980-07-04 Therapeutically active substituted piperidine carboxyllic amides
DK290180A DK290180A (da) 1979-07-10 1980-07-04 Fremgangsmaade til fremstilling af substituerede piperidiner eller pyrrolidiner
FI802173A FI802173A (fi) 1979-07-10 1980-07-07 Terapeutiskt aktiva substituerade piperidiner och pyrrolidiner
JP9232480A JPS5681561A (en) 1979-07-10 1980-07-08 Anilide derivative* its manufacture and its use
PL1980225542A PL125596B1 (en) 1979-07-10 1980-07-08 Process for preparing therapeutically active derivatives of piperidine
NZ194284A NZ194284A (en) 1979-07-10 1980-07-09 Piperidine and pyrrolidine derivatives and pharmaceutical compositions
ES493230A ES8107185A1 (es) 1979-07-10 1980-07-09 Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
CS804889A CS227011B2 (en) 1979-07-10 1980-07-09 Method of preparing substituted piperidines
HU80801712A HU180156B (en) 1979-07-10 1980-07-09 Process for preparing substituted piperidine derivatives
NO802062A NO802062L (no) 1979-07-10 1980-07-09 Terapeutisk aktive, substituerte piperidiner og pyrrolidiner
GR62416A GR69077B (es) 1979-07-10 1980-07-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7906000A SE431092B (sv) 1979-07-10 1979-07-10 Terapeutiskt aktiva, substituerade piperidinkarboxianilider

Publications (2)

Publication Number Publication Date
SE7906000L SE7906000L (sv) 1981-01-20
SE431092B true SE431092B (sv) 1984-01-16

Family

ID=20338488

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7906000A SE431092B (sv) 1979-07-10 1979-07-10 Terapeutiskt aktiva, substituerade piperidinkarboxianilider

Country Status (19)

Country Link
US (1) US4302465A (es)
EP (1) EP0024382B1 (es)
JP (1) JPS5681561A (es)
AT (1) ATE6507T1 (es)
AU (1) AU538494B2 (es)
CA (1) CA1162924A (es)
CS (1) CS227011B2 (es)
DE (1) DE3066827D1 (es)
DK (1) DK290180A (es)
ES (1) ES8107185A1 (es)
FI (1) FI802173A (es)
GR (1) GR69077B (es)
HU (1) HU180156B (es)
IL (1) IL60390A (es)
NO (1) NO802062L (es)
NZ (1) NZ194284A (es)
PL (1) PL125596B1 (es)
SE (1) SE431092B (es)
ZA (1) ZA803827B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443450A (en) * 1982-04-15 1984-04-17 Research Corporation Platelet aggregation inhibitory agents and intermediates therefor
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
US4859685A (en) * 1986-08-13 1989-08-22 Boc, Inc. Anesthetic composition and method of using the same
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US6512120B1 (en) 2001-03-12 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine intermediates
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) * 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US7910641B2 (en) 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
AU2007207503A1 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film bandage for mucosal administration of actives
CN101516331A (zh) 2006-09-20 2009-08-26 莫诺索尔克斯有限公司 含有抗泡沫调味剂的可食用水溶性膜
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
JP5819949B2 (ja) 2010-06-10 2015-11-24 ミダテック リミテッド ナノ粒子フィルム送達システム
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
AU2016359706B2 (en) 2015-11-23 2022-07-28 Acasti Pharma U.S., Inc. Topical film-forming spray
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
JP2019519487A (ja) 2016-05-05 2019-07-11 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
EA202191506A1 (ru) 2018-12-19 2021-10-08 Нортик Холдингз Инк. Терапевтическая композиция интраназального лидокаина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE164063C1 (es) 1958-07-22
SE191322C1 (es) 1964-01-01
SE191321C1 (es) 1964-01-01
US2792399A (en) * 1954-05-29 1957-05-14 Bofors Ab Anilides of heterocyclic compounds
US2799679A (en) * 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB889225A (es) * 1959-07-01
NL6803337A (es) 1967-03-20 1968-09-23
SE7607114L (sv) * 1976-06-22 1977-12-23 Bofors Ab Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
US4146628A (en) * 1977-08-04 1979-03-27 Edna Oppenheimer Antiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compounds
DE2742582A1 (de) * 1977-09-22 1979-04-05 Hoechst Ag Substituierte piperidinhydroxyamide, ihre herstellung und verwendung als lichtschutzmittel

Also Published As

Publication number Publication date
US4302465B1 (es) 1984-01-24
NO802062L (no) 1981-01-12
IL60390A (en) 1984-10-31
PL225542A1 (es) 1981-12-23
PL125596B1 (en) 1983-05-31
EP0024382B1 (en) 1984-03-07
ES493230A0 (es) 1981-08-16
JPS5681561A (en) 1981-07-03
HU180156B (en) 1983-02-28
AU538494B2 (en) 1984-08-16
DK290180A (da) 1981-01-11
DE3066827D1 (en) 1984-04-12
JPS6135178B2 (es) 1986-08-12
ZA803827B (en) 1981-06-24
EP0024382A1 (en) 1981-03-04
FI802173A (fi) 1981-01-11
CA1162924A (en) 1984-02-28
ES8107185A1 (es) 1981-08-16
CS227011B2 (en) 1984-04-16
US4302465A (en) 1981-11-24
AU6003280A (en) 1981-01-15
NZ194284A (en) 1983-06-14
SE7906000L (sv) 1981-01-20
GR69077B (es) 1982-04-26
ATE6507T1 (de) 1984-03-15

Similar Documents

Publication Publication Date Title
SE431092B (sv) Terapeutiskt aktiva, substituerade piperidinkarboxianilider
DE69525355T2 (de) 1-acyl-4-aliphatische aminopiperidin verbindungen
DE2634288A1 (de) Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4311706A (en) Novel dopa/dopamine prodrugs
PT88460B (pt) Processo para a preparacao de 1-{ (2-pirimidinil)-aminoalquil}-piperidinas e de composicoes farmaceuticas que as contem
DE69027221T2 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
US5221692A (en) Ether linked and relatively nonpungent analogues of N-nonanoyl vanillylamide
DE2640920B2 (es)
DE60013818T2 (de) Quaternäre ammoniumverbindungen, verfahren zu deren herstellung und deren pharmazeutische verwendung
DE3789395T2 (de) Alkylendiamin-Derivate.
DE69320653T2 (de) Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
US4340603A (en) Novel inotropic prodrugs
DE2751571A1 (de) Stereoisomere von 1-(1'-benzyl-2'- pyrryl)-2-di-sek.-butylaminoaethanol, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE69829654T2 (de) Verfahren zur herstellung von rhizoferrin
DE69623602T2 (de) Arginnin analoge mit no- syntax inhibierenderwirkung
DE2833892A1 (de) 12h-dibenzo eckige klammer auf d,g eckige klammer zu eckige klammer auf 1,3,6 eckige klammer zu dioxazocinderivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben
DE2064061C3 (de) Neue tuberkulostatisch wirkende alpha-Aminoxycarbonsäurederivate, Verfahren zur Herstellung derselben und diese enthaltende pharmazeutische Präparate
DE2311067C2 (de) Diphenylmethoxyäthylamine, Verfahren zu deren Herstellung und Verwendung von Diphenylmethoxyäthylaminen bei der Bekämpfung der Parkinson-Krankheit
DE3207813C2 (es)
DE69600780T2 (de) 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung
DE2654888A1 (de) Diphenylacetamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH670638A5 (es)
US2928872A (en) Dialkylaminoalkyl hydantoamides
DE69106276T2 (de) Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.
US20230278953A1 (en) Water soluble prodrugs of ptba for use in hdac inhibition and enhancing renal recovery following acute kidney injury

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7906000-0

Effective date: 19880620

Format of ref document f/p: F